Bod Science battles for its future as board calls in administrators by Steve Jones November 30, 2023November 30, 2023 The future of Bod Science is hanging in the balance after it entered voluntary administration amid […]
Bod announces A$2m capital raise as senior team takes pay cut by Martin Lane November 8, 2023November 9, 2023
Bod eyes opportunities beyond cannabis as Aqua Phase tech passes second bioavailability test by Martin Lane September 27, 2023September 27, 2023
Long-time cannabis critic says medicine’s growth ‘more concerning’ than opioid epidemic by Martin Lane September 18, 2023September 20, 2023
Cannabis executive salaries: who earned what in FY23 by Steve Jones September 13, 2023September 14, 2023
Bod Science clinical trial ‘proves the efficacy of CBD’ for pharmacy sales by Steve Jones September 6, 2023September 7, 2023
Bod plotting ‘immediate’ overseas move if CBD sleep trial succeeds by Steve Jones July 19, 2023July 20, 2023
Bod Science faces nervy wait as final patient completes S3 clinical trial by Steve Jones July 10, 2023July 13, 2023
Bod Science to test drug-delivery tech on psychiatric medication by Steve Jones May 31, 2023May 31, 2023
